Terms: = Sarcomas AND FANCD2, FANCD, 2177, ENSG00000144554, FLJ23826, FAD, FACD, FA4, FA-D2, FAD2, DKFZp762A223
20 results:
1. Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study.
Liu X; Gong C; Zhang J; Feng W; Guo Y; Sang Y; Wang C; Chen Y; Wang J; Yu L; Zhang X; Luo Z
Cancer Res Treat; 2023 Jul; 55(3):1001-1010. PubMed ID: 36915248
[TBL] [Abstract] [Full Text] [Related]
2. fancd2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma.
Li X; Liu J
BMC Cancer; 2023 Feb; 23(1):179. PubMed ID: 36814203
[TBL] [Abstract] [Full Text] [Related]
3. Impaired Fanconi anemia pathway causes DNA hypomethylation in human angiosarcomas.
Zhu K; Sun S; Guo F; Gao L
Hum Cell; 2022 Sep; 35(5):1602-1611. PubMed ID: 35817884
[TBL] [Abstract] [Full Text] [Related]
4. The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor.
Shibui Y; Kohashi K; Tamaki A; Kinoshita I; Yamada Y; Yamamoto H; Taguchi T; Oda Y
J Cancer Res Clin Oncol; 2021 May; 147(5):1499-1518. PubMed ID: 33221995
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of FANCL variants observed in patient cancer cells.
Frost MG; Mazloumi Aboukheili AM; Toth R; Walden H
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32420600
[TBL] [Abstract] [Full Text] [Related]
6. fancd2 protects genome stability by recruiting RNA processing enzymes to resolve R-loops during mild replication stress.
Okamoto Y; Abe M; Itaya A; Tomida J; Ishiai M; Takaori-Kondo A; Taoka M; Isobe T; Takata M
FEBS J; 2019 Jan; 286(1):139-150. PubMed ID: 30431240
[TBL] [Abstract] [Full Text] [Related]
7. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
Venigalla S; Chowdhry AK; Shalowitz DI
Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
[TBL] [Abstract] [Full Text] [Related]
8. The Landscape of Viral Expression Reveals Clinically Relevant Viruses with Potential Capability of Promoting Malignancy in Lower-Grade Glioma.
Wang Z; Hao Y; Zhang C; Wang Z; Liu X; Li G; Sun L; Liang J; Luo J; Zhou D; Chen R; Jiang T
Clin Cancer Res; 2017 May; 23(9):2177-2185. PubMed ID: 27864420
[No Abstract] [Full Text] [Related]
9. Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics.
Engert F; Kovac M; Baumhoer D; Nathrath M; Fulda S
Oncotarget; 2017 Jul; 8(30):48794-48806. PubMed ID: 27447864
[TBL] [Abstract] [Full Text] [Related]
10. BLM promotes the activation of Fanconi Anemia signaling pathway.
Panneerselvam J; Wang H; Zhang J; Che R; Yu H; Fei P
Oncotarget; 2016 May; 7(22):32351-61. PubMed ID: 27083049
[TBL] [Abstract] [Full Text] [Related]
11. Forkhead transcription factor FoxF1 interacts with Fanconi anemia protein complexes to promote DNA damage response.
Pradhan A; Ustiyan V; Zhang Y; Kalin TV; Kalinichenko VV
Oncotarget; 2016 Jan; 7(2):1912-26. PubMed ID: 26625197
[TBL] [Abstract] [Full Text] [Related]
12. First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma: A Phase 2b Randomized Clinical Trial.
Chawla SP; Papai Z; Mukhametshina G; Sankhala K; Vasylyev L; Fedenko A; Khamly K; Ganjoo K; Nagarkar R; Wieland S; Levitt DJ
JAMA Oncol; 2015 Dec; 1(9):1272-80. PubMed ID: 26378637
[TBL] [Abstract] [Full Text] [Related]
13. Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast.
Vidal M; Peg V; Galván P; Tres A; Cortés J; Ramón y Cajal S; Rubio IT; Prat A
Mol Oncol; 2015 Jun; 9(6):1081-90. PubMed ID: 25687451
[TBL] [Abstract] [Full Text] [Related]
14. fancd2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene.
Singh M; Leasure JM; Chronowski C; Geier B; Bondra K; Duan W; Hensley LA; Villalona-Calero M; Li N; Vergis AM; Kurmasheva RT; Shen C; Woods G; Sebastian N; Fabian D; Kaplon R; Hammond S; Palanichamy K; Chakravarti A; Houghton PJ
Clin Cancer Res; 2014 Jul; 20(14):3884-95. PubMed ID: 24787670
[TBL] [Abstract] [Full Text] [Related]
15. Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer.
Colombo PE; Fabbro M; Theillet C; Bibeau F; Rouanet P; Ray-Coquard I
Crit Rev Oncol Hematol; 2014 Feb; 89(2):207-16. PubMed ID: 24071502
[TBL] [Abstract] [Full Text] [Related]
16. Regulation of fancd2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double-strand breaks.
Shen C; Oswald D; Phelps D; Cam H; Pelloski CE; Pang Q; Houghton PJ
Cancer Res; 2013 Jun; 73(11):3393-401. PubMed ID: 23633493
[TBL] [Abstract] [Full Text] [Related]
17. Human KIAA1018/FAN1 nuclease is a new mitotic substrate of APC/C(Cdh1).
Lai F; Hu K; Wu Y; Tang J; Sang Y; Cao J; Kang T
Chin J Cancer; 2012 Sep; 31(9):440-8. PubMed ID: 22854063
[TBL] [Abstract] [Full Text] [Related]
18. Use of self-expanding vascular endoprostheses in superior vena cava syndrome.
García Mónaco R; Bertoni H; Pallota G; Lastiri R; Varela M; Beveraggi EM; Vassallo BC
Eur J Cardiothorac Surg; 2003 Aug; 24(2):208-11. PubMed ID: 12895609
[TBL] [Abstract] [Full Text] [Related]
19. [Poor prognosis of osteosarcoma of pelvis; 39 years of registration by the Netherlands Commission on Bone Tumors].
Ham SJ; Kroon HM; Schraffordt Koops H; Hoekstra HJ
Ned Tijdschr Geneeskd; 2000 Jan; 144(3):121-5. PubMed ID: 10674118
[TBL] [Abstract] [Full Text] [Related]
20. Thermoradiotherapy for superficial tumour deposits in the head and neck.
Engin K; Tupchong L; Waterman FM; Cater JR; Koppel A; Dietz D; Hoh L; McFarlane JD; Leeper DB
Int J Hyperthermia; 1994; 10(2):153-64. PubMed ID: 8064177
[TBL] [Abstract] [Full Text] [Related]
